TrkA
Showing 1 - 25 of 43
Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Korea, Republic of, United States (Entrectinib)
Completed
- Locally Advanced Solid Tumors
- Metastatic Solid Tumors
-
Orange, California
- +9 more
Jun 7, 2021
Erectile Dysfunction Trial in Terni (A peripheral blood sample from the cubital vein)
Unknown status
- Erectile Dysfunction
- A peripheral blood sample from the cubital vein
-
Terni, ItalyElisabetta Costantini
Mar 2, 2019
Solid Tumor Trial (TL118 Capsule)
Not yet recruiting
- Solid Tumor
- TL118 Capsule
- (no location specified)
Aug 18, 2023
Chronic OA Pain and Cognition Deficits in OA Patients.
Completed
- Knee Osteoarthritis
- Neuroinflammatory Response
-
Kaohsiung city, Zuoying Dist, TaiwanKaohsiung Veterans General Hopital
Oct 4, 2022
Phase 1, Solid Tumor, Adult Trial in Goyang, Seongnam, Seoul (NOV1601(CHC2014))
Completed
- Phase 1
- Solid Tumor, Adult
-
Goyang, Gyeonggi-do, Korea, Republic of
- +3 more
Sep 8, 2021
A Retro-/Prospective, Non-interventional, Cohort Study in Adult
Active, not recruiting
- Solid Tumor, Adult
- +2 more
-
Amiens, France
- +3 more
Jul 22, 2022
Soft Tissue Sarcoma, Advanced Cancer, Metastatic Cancer Trial in France (Blood and tumor samples)
Recruiting
- Soft Tissue Sarcoma
- +2 more
- Blood and tumor samples
-
Clermont-Ferrand, France
- +9 more
Dec 8, 2021
Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Houston (Larotrectinib Sulfate)
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- Metastatic Malignant Solid Neoplasm
- Larotrectinib Sulfate
-
Houston, TexasM D Anderson Cancer Center
Apr 18, 2022
Overactive Bladder, Underactive Bladder Trial in Taichung (prolotherapy)
Recruiting
- Overactive Bladder
- Underactive Bladder
- prolotherapy
-
Taichung, Other (Non US), TaiwanTaichung Armed Forces General Hospital
Jul 31, 2022
Genetic Sequencing of Early Gastric Cancer and Gastric Adenoma
Recruiting
- Early Gastric Cancer
- Gastric Adenoma
-
Seoul, Korea, Republic ofSamsung medical center
Dec 17, 2020
Colorectal Adenocarcinoma, Colon Cancer, Colon Adenocarcinoma Trial in United States (Cabozantinib, Nivolumab)
Recruiting
- Colorectal Adenocarcinoma
- +6 more
-
Aurora, Colorado
- +4 more
Nov 19, 2021
Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Larotrectinib (Vitrakvi, BAY2757556))
Recruiting
- Solid Tumors Harboring NTRK Fusion
- Larotrectinib (Vitrakvi, BAY2757556)
-
Los Angeles, California
- +50 more
Jan 29, 2023
Lymphoblastic Leukemia, Acute, Adult, Ph Negative ALL, Newly Diagnosed Trial in Czechia (Blinatumomab)
Active, not recruiting
- Lymphoblastic Leukemia, Acute, Adult
- +2 more
-
Brno, Czechia
- +4 more
Aug 3, 2022
Lymphoblastic Lymphoma Trial in Chengdu, Shanghai (Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide,
Active, not recruiting
- Lymphoblastic Lymphoma
- Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine
- +6 more
-
Chengdu, China
- +1 more
Mar 17, 2022
Solid Tumors Harboring NTRK Fusion Trial in United States (Larotrectinib (Vitrakvi, BAY2757556))
Completed
- Solid Tumors Harboring NTRK Fusion
- Larotrectinib (Vitrakvi, BAY2757556)
-
Aurora, Colorado
- +7 more
May 11, 2021
Hormone Refractory Prostate Cancer Trial in Seoul (TKI258)
Completed
- Hormone Refractory Prostate Cancer
-
Seoul, Chongro-ku, Korea, Republic of
- +1 more
Feb 16, 2021
Solid Tumors Harboring NTRK Fusion Trial in Worldwide (BAY2757556 (Larotrectinib, Vitrakvi))
Recruiting
- Solid Tumors Harboring NTRK Fusion
- BAY2757556 (Larotrectinib, Vitrakvi)
-
Palo Alto, California
- +158 more
Aug 8, 2022
Intra Cerebral Hemorrhage, Stroke Hemorrhagic Trial in Baltimore (Supine cycle ergometry of the lower extremities)
Recruiting
- Intra Cerebral Hemorrhage
- Stroke Hemorrhagic
- Supine cycle ergometry of the lower extremities
-
Baltimore, MarylandJohns Hopkins University
Jan 23, 2023
Multiple Sclerosis, Exercise Intervention, Neuro-Degenerative Disease Trial in Izmir (Regular Exercise)
Completed
- Multiple Sclerosis
- +2 more
- Regular Exercise
-
Izmir, Bornova, TurkeyEge University
Jun 25, 2021
Glioblastoma Multiforme Trial run by the NCI (AZD7451)
Completed
- Glioblastoma Multiforme
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
Minimal Residual Disease asPossible Predictive Factor for
Completed
- Amyloidosis
- Primary Amyloidosis
-
Boston, MassachusettsTufts Medical Center
Aug 21, 2020